⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE)
prnewswire.com
JNJ
Kivu Bioscience Appoints Brunilda Shtylla as Chief Business Officer
businesswire.com
EW
JNJ
Drug Discovery Leader Marcus Schindler Joins Cradle's Advisory Board
prnewswire.com
JNJ
ABBV
NVO
EcoVadis Launches Peer-to-Peer Community to Turn Sustainability Insight into Shared Progress
prnewswire.com
JNJ
UL
JPM
COMPUTEX 2026 Brings the Global AI Ecosystem to Taipei
prnewswire.com
MSI
INTC
TXN
NVDA
AMAT
KLAC
LRCX
MU
QCOM
AMD
GOOG
MSFT
AMZN
IBM
DELL
HPQ
VRTX
ADI
NXPI
ON
MCHP
SNPS
CDNS
MRVL
ADSK
CTAS
PAYX
ADP
CRM
NOW
PANW
FTNT
ZBRA
HON
GE
ROK
ETN
GOOGL
META
NFLX
DIS
CMCSA
T
VZ
TMUS
CSCO
ORCL
SAP
ACN
DXC
WDC
SE
SMCI
DDOG
MDB
ZS
CRWD
SNOW
PLTR
UPST
COIN
PYPL
AFRM
SOFI
HOOD
UPWK
FIVN
RBLX
EA
TTWO
U
EXAS
REGN
BIIB
GILD
AMGN
BMY
PFE
MRK
JNJ
ABBV
LLY
NVO
AZN
XOM
CVX
SHEL
BABA
JD
PDD
NTES
BIDU
VIPS
EDU
BEKE
TAL
BILI
RLX
XPEV
NIO
LI
CPT
LCID
RIVN
TSLA
GM
F
STLA
VWAGY
HOG
YETI
GOOS
LULU
UA
NKE
ANF
AEO
URBN
PVH
RL
TJX
M
BBY
WMT
COST
TGT
HD
LOW
SPG
PLD
AMT
EQIX
CCI
DLR
SBAC
Global Implanted Brain-Computer Interface Devices Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight
prnewswire.com
LIVN
SNAP
GE
BSX
JNJ
PFE
MRK
BMY
LLY
NVO
PHG
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
businesswire.com
JNJ
Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight
globenewswire.com
BMY
JNJ
Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence
globenewswire.com
JNJ
BMY
SNY
PFE
BAX
NVS
GSK
SUN
Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence
globenewswire.com
JNJ
BMY
PFE
BAX
GSK
SUN